Rio Preto confirms two cases of monkeypox

Rio Preto confirmed this Monday, August 1, the first two cases of monkeypox – a disease transmitted by the monkeypox virus. The victims are two men aged 33 and 34, residents of Rio Preto, monitored by Epidemiological Surveillance.

According to the record, the 33-year-old patient began exhibiting symptoms on July 23. The other man began showing symptoms on July 26. Both had the result confirmed for Monkeypox last Saturday, the 30th. It was not disclosed whether they needed medical attention, or if they had been infected while traveling to other cities or countries.

With the confirmation of the first two in Rio Preto, the region has three positive cases of monkeypox. Noroeste Paulista’s first record was produced by a 33-year-old man from Bady Bassitt. According to the town hall, he presented the first symptoms of the disease after returning from a trip to Argentina. He was admitted to the base hospital, but due to his satisfactory clinical condition, he was discharged.

According to the Municipal Health Coordination of Bady Bassitt, last Thursday July 28, the patient is out of the disease. In total, the state of São Paulo has 1,031 positive cases of Monkeypox since the first diagnosis, made public on June 9. The only death from the disease confirmed so far in Brazil is a 41-year-old man, who died last Friday, the 29th, in Belo Horizonte (MG). Nationwide, so far, there are 1,369 positive cases.

The disease is transmitted by a virus from the same family as smallpox and has caused the World Health Organization (WHO) to declare a public health emergency of international importance. Worldwide, 21,099 cases of the disease had been confirmed by late Monday afternoon.

To the best of our knowledge, monkeypox is transmitted by close or intimate contact with an infected person with broken skin or by contact with objects, fabrics and surfaces that have been used on the skin of infected people, such as nail clippers, for example. .

Despite its name, there is no involvement of monkeys in transmission to humans. Key symptoms, which last between two and four weeks, include pimple-like or blister-like lesions on the face, inside of the mouth, hands, feet, chest, genitals, or anus . A lump in the neck, armpits and groin is also common.

Other common symptoms in patients diagnosed with monkeypox are fever, headache, chills, fatigue, and muscle aches. The guideline is that people who have traveled within the last month monitor their symptoms and, if suspected, seek medical attention.

As a preventive measure, health authorities also recommend avoiding intimate or sexual contact with people with skin lesions, avoiding sharing bedding, towels, cutlery, cups and personal items, wearing a mask and wash your hands frequently.

The country will receive an antiviral, says Saúde

The Minister of Health, Marcelo Queiroga, declared this Monday 1st, on his Twitter profile, that Brazil would receive the antiviral tecovirimat to fight against monkeypox. Last Friday, the 29th, the ministry confirmed the first death from the disease in the country, in Belo Horizonte (MG).

“The Ministry of Health will receive, through PAHO (@pahowho), the antiviral tecovirimat to strengthen the fight against the Monkeypox epidemic in Brazil. More serious cases will be considered first,” Queiroga wrote, referring to the Pan American Health Organization (PAHO). The minister, however, did not specify when the country will receive the antiviral, or the number of doses.

On June 23, the World Health Organization (WHO) declared monkeypox a global health emergency, given the spread of the disease and the risk of contamination.

The Ministry of Health set up an emergency group on Friday 29 to deal with the spread of monkeypox (monkeypox) in the country. The Emergency Operations Center (COE) brings together representatives from different sectors of the federation, such as Anvisa, Conass and Conasems. Even with this measure, experts and health officials stress that the ministry still needs to expand its testing capacity, develop public awareness campaigns with a sense of urgency and restart negotiations for vaccine acquisition.

During a press conference, the secretary of health surveillance, Arnaldo Medeiros, declared that the “main objective” of the WCC is to draw up an emergency plan, with analysis of epidemiological information on the disease. (State Agency)


1- What is monkeypox?

Monkeypox is a sylvatic zoonosis, that is to say a virus which infects monkeys, but which can incidentally infect humans.

There are two types of monkeypox virus: West Africa and Congo Basin (Central Africa)

The case fatality rate for the West African virus is 1%, while for the Congo Basin virus it can reach 10%.

Children are also more at risk, and smallpox during pregnancy can lead to complications, congenital smallpox or the death of the baby, points out the WHO.

2- What are the symptoms of the disease?

Fever, headache, muscle aches, back pain, swollen lymph nodes, chills and exhaustion

Skin lesions first develop on the face and then spread to other parts of the body, including the genitals

Skin lesions resemble those of chicken pox or syphilis until they form
a crust, which then falls off.

Symptoms can be mild or severe, and skin lesions can be itchy or painful.

3- How contagion occurs

It can be transmitted by contact with droplets exhaled by an infected person (human or animal) or by contact with skin lesions caused by the disease or contaminated materials such as clothing and linens. It can also be transmitted through sexual contact

The incubation period for monkeypox is usually 6 to 13 days, but can range from 5 to 21 days. Infected people must therefore be isolated and under observation for 21 days.

4- How the disease was identified

It was first discovered in 1958, when two outbreaks of a smallpox-like disease occurred in research colonies of monkeys.

The first human case was recorded in 1970 in the Democratic Republic of Congo.

In this 2022 outbreak, the first case was identified in England in a man who developed skin lesions on May 5.

Historically, smallpox vaccination has been shown to be protective against monkeypox.

Although a vaccine (MVA-BN) and a specific treatment (tecovirimat) were approved for smallpox in 2019 and 2022 respectively, these countermeasures are still not widely available.

Residents of and travelers from endemic countries should avoid contact with sick animals (dead or alive) that may harbor monkeypox virus (rodents, marsupials and primates) and should refrain from eating or handle wild game.

Hand hygiene with soap and water or alcohol gel is important to avoid exposure to the virus

Avoid contact with infected people

Avoid using items from contaminated people and people with skin lesions

Source: Butantan Institute

Leave a Comment